Grant: Alliance Grants
Université d'Ottawa
$25,000.00
Navigating the Bloodstream: Optimizing Bacterial Strategies for Targeted Cancer Therapy
FY 2024-25
Summary
Addressing the global health challenge of cancer, this project will explore the innovative use of bacteriotherapy for targeted cancer treatment through the bloodstream. Although progress has been made in this area, the complex interaction between hydrodynamic effects and bacterial properties, such as blood cell dynamics and cellular motility in blood environments, remains largely unexplored. Our multidisciplinary team will aim to develop genetically modified bacteria to better understand these dynamics and contribute to the improvement of bacteriobots - entities inspired by bacteria - as potential therapeutic delivery agents in tumor environments. Using microfluidic devices and microPIV technology, we will study bacterial motility under conditions simulating blood flow and tumor microenvironments. This research aims to lay the foundation for future advances in bacteriobots for cancer therapy, contributing to a deeper understanding of their potential as targeted treatment agents.
The project aims to design and synthesize bacteria with enhanced motility capabilities to effectively target synthetic synthetic tumor cell environments. The project is divided into three sub-projects led by experts in molecular and synthetic biology, physical engineering, and fluid dynamics. The first sub-project focuses on the design and synthesis of bacteria with variations in flagellar number, fluorescent characteristics, and refined sensory systems to create a library of diverse bacterial behaviors. The second sub-project focuses on the characterization of individual and collective bacterial swimming using microfluidic devices that generate quasi-static flow conditions to evaluate in detail bacterial motility and chemotaxis. Finally, the third sub-project focuses on the study of bacterial dynamics in blood and how blood properties, such as red blood cell concentration, aggregation, and deformability, affect bacterial movement. The project integrates an international collaboration to provide enriching learning experiences for research students and promote equity, diversity, and inclusion in the research environment.
Program
Alliance Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
597386-2024
Name nom
Fenech, Marianne MMS
Department département
Engineering, Faculty of
Organization id
28
Institution établissement
Université d'Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Navigating the Bloodstream: Optimizing Bacterial Strategies for Targeted Cancer Therapy
Keywords
bacterial-mediated cancer therapy; bacterioboots; bacterioterapy; cancer; hemodynamics; microfluidics; micropiv; motility
Application summary
Addressing the global health challenge of cancer, this project will explore the innovative use of bacteriotherapy for targeted cancer treatment through the bloodstream. Although progress has been made in this area, the complex interaction between hydrodynamic effects and bacterial properties, such as blood cell dynamics and cellular motility in blood environments, remains largely unexplored. Our multidisciplinary team will aim to develop genetically modified bacteria to better understand these dynamics and contribute to the improvement of bacteriobots - entities inspired by bacteria - as potential therapeutic delivery agents in tumor environments. Using microfluidic devices and microPIV technology, we will study bacterial motility under conditions simulating blood flow and tumor microenvironments. This research aims to lay the foundation for future advances in bacteriobots for cancer therapy, contributing to a deeper understanding of their potential as targeted treatment agents.
The project aims to design and synthesize bacteria with enhanced motility capabilities to effectively target synthetic synthetic tumor cell environments. The project is divided into three sub-projects led by experts in molecular and synthetic biology, physical engineering, and fluid dynamics. The first sub-project focuses on the design and synthesis of bacteria with variations in flagellar number, fluorescent characteristics, and refined sensory systems to create a library of diverse bacterial behaviors. The second sub-project focuses on the characterization of individual and collective bacterial swimming using microfluidic devices that generate quasi-static flow conditions to evaluate in detail bacterial motility and chemotaxis. Finally, the third sub-project focuses on the study of bacterial dynamics in blood and how blood properties, such as red blood cell concentration, aggregation, and deformability, affect bacterial movement. The project integrates an international collaboration to provide enriching learning experiences for research students and promote equity, diversity, and inclusion in the research environment.